To read the full story, subscribe or sign in.

Financings for February 4, 2025

Feb. 4, 2025

No Comments

Biopharmas in Asia-Pacific raising money in public or private financings: Ascentage.

BioWorld Asia Briefs Financings

Today's news in brief

BioWorld

BioWorld briefs for Feb. 6, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for February 6, 2025

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...

Radiopharma Advancell raises $112M in series C for alpha therapies

BioWorld

Aussie radiopharma company Advancell Co. Ltd. closed an oversubscribed $112 million series C round that will accelerate clinical development of its pipeline of...

Novo weight-loss data roll out; Veru ‘leans’ in

BioWorld

As investors look ahead to data shortly from Veru Inc. with enobosarm, the weight-loss space remains hot, with Novo Nordisk A/S reporting favorable top-line...